A2 Biotherapeutics

A2 Biotherapeutics is a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies. Their proprietary Tmod™ platform targets tumor cells while protecting normal cells. This precision approach addresses a critical challenge in cancer treatment.

Buy Funded Startups lists

Funding Round: Series C

Funding Amount: $80M

Date: 09-Jan-2025

Investors: The Column Group, Samsara BioCapital

Markets: Biotechnology, Cell Therapy, Oncology

HQ: Agoura Hills, California, United States

Founded: 2018

Website: https://www.a2bio.com/

LinkedIn: https://www.linkedin.com/company/a2-biotherapeutics

Twitter:

Instagram: